S, T., P, A., L, L., H, P., C, K., MA, M., & M, S. (2026). Prenatal initiation of elexacaftor/tezacaftor/ivacaftor via carrier mother prevents congenital bilateral absence of vas deferens in a male infant with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 25(4), 609. https://doi.org/10.1016/j.jcf.2026.02.001
Παραπομπή σε μορφή Chicago (17η εκδ.)S, Thee, Aleksander P, Lechner L, Posch H, Koegel C, Mall MA, και Stahl M. "Prenatal Initiation of Elexacaftor/tezacaftor/ivacaftor via Carrier Mother Prevents Congenital Bilateral Absence of Vas Deferens in a Male Infant with Cystic Fibrosis." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 25, no. 4 (2026): 609. https://doi.org/10.1016/j.jcf.2026.02.001.
Παραπομπή σε μορφή MLA (9th εκδ.)S, Thee, et al. "Prenatal Initiation of Elexacaftor/tezacaftor/ivacaftor via Carrier Mother Prevents Congenital Bilateral Absence of Vas Deferens in a Male Infant with Cystic Fibrosis." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 25, no. 4, 2026, p. 609, https://doi.org/10.1016/j.jcf.2026.02.001.